MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: New diabetes drug may also cause weight reduction

Back to diabetes watch blog Blogs list Cancer blog  


Subscribe To Diabetes Watch Blog RSS Feed  RSS content feed What is RSS feed?

New Diabetes Drug May Also Cause Weight Reduction

New diabetes drug may also cause weight reduction Cris Welling
The Washington University Diabetes Center at Barnes-Jewish Hospital focuses on providing patients with the latest technology, therapys and clinical research. Some patients at the center are receiving a new diabetes drug that may give a welcome side effect - weight loss.

Byetta, developed by Amylin Pharmaceuticals and Eli Lilly and Co., is designed to help patients with type 2 diabetes get better control of their condition by helping the body make more of its own insulin. The drug, a twice-daily injection, tells the pancreas to make the right amount of insulin after meals to bring blood sugar closer to normal levels. It also helps stop the liver from producing too much sugar when the body doesn't need it, and helps slow down the rate at which sugar enters the bloodstream. It is typically used along with oral diabetes medications, and in some patients, it has led to weight loss.

One of the patients taking Byetta is Cris Welling, a research lab supervisor in the endocrinology/metabolism lab of M. Alan Permutt, M.D., professor of medicine and of cell biology and physiology. About five years ago, Welling volunteered to be a non-diabetic control in a University research study. When she went through the initial tests, she found out she had pre-diabetes.

Welling's physician, Garry Tobin, M.D., associate professor of medicine and medical director of the diabetes center, had prescribed several other oral medications to treat her diabetes, but none helped her to lose weight. Since she began taking Byetta for type 2 diabetes about 10 months ago, she has lost about 40 pounds. She no longer needs medicine for hypertension and has reduced the medicine she takes for high cholesterol.

Tobin says Welling is a success story.

"Because of her participation in research at the School of Medicine, she was diagnosed at an early stage," Tobin says. "She has access to the clinical care of multiple people at the School of Medicine, which gives her access to newer drugs."

Byetta is not approved as a weight-loss drug, Tobin said, because it works to regulate blood sugar. People who do not have diabetes and take the drug could suffer from hypoglycemia, or dangerously low blood sugar.



Posted by: JoAnn    Source




Did you know?
The Washington University Diabetes Center at Barnes-Jewish Hospital focuses on providing patients with the latest technology, therapys and clinical research. Some patients at the center are receiving a new diabetes drug that may give a welcome side effect - weight loss. Byetta, developed by Amylin Pharmaceuticals and Eli Lilly and Co., is designed to help patients with type 2 diabetes get better control of their condition by helping the body make more of its own insulin. The drug, a twice-daily injection, tells the pancreas to make the right amount of insulin after meals to bring blood sugar closer to normal levels. It also helps stop the liver from producing too much sugar when the body doesn't need it, and helps slow down the rate at which sugar enters the bloodstream. It is typically used along with oral diabetes medications, and in some patients, it has led to weight loss.

Medicineworld.org: New diabetes drug may also cause weight reduction

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.